Affordable Access

Buspirone therapy for maladaptive behavior and anxiety in developmentally disabled persons.

Authors
Type
Published Article
Journal
The Journal of clinical psychiatry
Publication Date
Volume
50
Issue
10
Pages
382–384
Identifiers
PMID: 2793836
Source
Medline

Abstract

The authors used buspirone, a new anxiolytic agent that has a low side effect profile, to treat 14 developmentally disabled individuals who demonstrated anxiety as well as aggressive and self-injurious behaviors. Nine of the 14 individuals responded favorably to the drug. The authors present case reports for 3 of the responders and discuss the clinical implications of buspirone therapy.

There are no comments yet on this publication. Be the first to share your thoughts.

Statistics

Seen <100 times
0 Comments